Avigen, Inc. Announces Third Quarter 2006 Earnings Conference Call
October 23 2006 - 9:00AM
PR Newswire (US)
Avigen to Host Conference Call Wednesday, October 25, at 11:30 a.m.
(EDT) ALAMEDA, Calif., Oct. 23 /PRNewswire-FirstCall/ .- Avigen,
Inc. (NASDAQ: AVGN), a biopharmaceutical company developing
innovative therapies for the treatment of neurological conditions,
will hold its quarterly conference call to discuss third quarter
results on Wednesday, October 25, 2006, at 11:30 a.m. EDT (8:30
a.m. PDT). Kenneth Chahine, Chief Executive Officer, and Michael
Coffee, Chief Business Officer, can be heard by calling
800-561-2813 (U.S.) or 617-614-3529 (non-U.S. locations) using
passcode 80580784. This call is being webcast by Thomson/CCBN and
can be accessed at Avigen's website at http://www.avigen.com/. The
webcast is also being distributed through the Thomson StreetEvents
Network. Individual investors can listen to the call at
http://www.earnings.com/, Thomson's individual investor portal,
powered by StreetEvents. Institutional investors can access the
call via Thomson StreetEvents (http://www.streetevents.com/), a
password-protected event management site. A rebroadcast of the call
will be available shortly after the conclusion of the session. The
replay may be accessed over the Internet at http://www.avigen.com/
or by calling 888-286-8010 (U.S.) or 617-801-6888 (non- U.S.
locations) using passcode 75317634. About Avigen Avigen, Inc. is a
biopharmaceutical company focused on unique small molecule
therapeutics and biologics to treat serious, chronic neurological
disorders, including neuropathic pain and neuromuscular spasm and
spasticity. For press releases and other corporate information,
visit our website at http://www.avigen.com/. DATASOURCE: Avigen,
Inc. CONTACT: Michael Coffee, Chief Business Officer of Avigen,
Inc., +1-510-748-7372, or Web Site: http://www.avigen.com/
Copyright